Inogen, Inc
Inogen develops, manufactures, and markets portable oxygen concentrators for patients, physicians, and payors globally. Its concentrators deliver supplemental long-term oxygen therapy to chronic respiratory condition patients. The company offers portable Inogen One devices, stationary At Home units, airway clearance systems, batteries, and accessories. It also rents products directly to patients.
Overview
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 0.0%) has been below its cost of capital of 10.5% in each of the last 6 years.
- Our discounted cash flow model finds no value to support the current price: free cash flow is negative.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 5 of the last 6 years.
- High leverage: net debt is 9.0x EBITDA, against a median of 0.9x for its Medical Devices peers.
- Unstable profitability: operating margin ranged from -24% to 3% over the last 6 years, with operating losses in 5 of them.
Key Financial Data